week one on tirzepatide TrimRX Tirzepatide – Ready Med

Sure, they can help you sleep for a while

Participants were adults with: Obesity (BMI 30 kg/m) or Overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease No diabetes diagnosis Participants were randomized 1:1 to receive either: Maximum tolerated dose of Zepbound (10 mg or 15 mg) Maximum tolerated dose of Wegovy (1.7 mg or 2.4 mg) The study cohort had a mean age of 44.7 years, 64.7% were women, and participants had an average body weight of 249 pounds with a mean BMI of 39.4 kg/m

What is clear is the new retatrutide TRIUMPH-2 data demonstrates the greatest weight loss a obesity+T2D population has ever seen with a medication

BMI showed only a slight, non-significant reduction from 34.0 to 33.9

Minimal side effects include minor bruising or soreness at the injection site, but this usually goes away after a few days

This is a normal physiological response as the GLP-1 and GIP receptor agonism wanes